(3S,5R)-tert-Butyl 6-chloro-3,5-dihydroxyhexanoate
✓
データの正確性100%
24時間年中無休の科学サポート
⬡
品質に対する妥協ゼロ

在庫拠点

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* 在庫状況によります

Documentation

MSDSをダウンロード

サンプルCOAをダウンロード

内容: HPLC、MASS/LC-MS、1H NMR、FT-IR、含量、構造解析レポート(SER)、および製品に応じた追加分析データ。

404958-68-5(3S,5R)-tert-Butyl 6-chloro-3,5-dihydroxyhexanoate

● 在庫あり

カタログ番号:VE008984
CAS番号:404958-68-5
分子式:C10H19ClO4
分子量:238.71 g/mol

に関する追加情報 CAS 404958-68-5

親薬物

Rosuvastatin

IUPAC名

(3S, 5R)-tert-Butyl 6-chloro-3, 5-dihydroxyhexanoate

同義語

N/A

説明

It has significant LDL-C lowering potential, minimal potential for CYP3A4 interactions, and low extrahepatic tissue penetration. A completely synthesized HMG-CoA reductase inhibitor is rosuvastatin. Other HMG-CoA reductase inhibitors are either synthetically made from heptanoic acid or naturally produced from mevalonic acid (lovastatin, simvastatin, and pravastatin) (atorvastatin, fluvastatin). A novel class of 3, 5-dihydroxy-heptanoate and N-methane sulfonyl pyrrole-substituted methane sulphonamide pyrimidines include rosuvastatin. Including stable polar methane-sulphonamide group results in low lipophilicity and improved ionic interaction with the HMG-CoA reductase enzyme, enhancing its binding affinity to this enzyme even if the characteristic statin pharmacophore is comparable to that of other statins.

References

Luvai, Ahai, et al. “Rosuvastatin: A Review of the Pharmacology and Clinical Effectiveness in Cardiovascular Disease.” Clinical Medicine Insights: Cardiology, vol. 6, Jan. 2012, p. CMC.S4324, https://doi.org/10.4137/cmc.s4324. ‌

見積もり依頼

「*」は必須フィールドを示します

このフィールドは入力チェック用です。変更しないでください。
Products quotation
Name
Url